A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Status:
RECRUITING

Trial end date:
2028-12-31

Target enrollment:

Participant gender:

A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)

PHASE1

Novartis Pharmaceuticals